Compare Amphastar Pharmaceuticals Inc (AMPH) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Vipshop Holdings Ltd - ADR — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.72 (market cap $826.08M), while Vipshop Holdings Ltd - ADR trades at $13.94 (market cap $6.69B). The key difference: Vipshop Holdings Ltd - ADR is far larger — about 8.1× Amphastar Pharmaceuticals Inc's market cap, and Vipshop Holdings Ltd - ADR pays a 4.45% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | VIPS | |
|---|---|---|
Market Cap | $826.08M | $6.69B |
Sector | Health | Consumer Cyclical |
52-Week High | $30.81 | $20.68 |
52-Week Low | $16.87 | $12.92 |
Enterprise Value | $1.22B | $3.29B |
Dividend Yield | — | 4.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
Vipshop Holdings (VIPS) trades at $13.94, up 0.65% with a bullish technical signal despite mixed earnings history. The stock shows attractive valuation metrics with P/E of 6.36 and P/S of 0.45, supported by solid profitability including 18.43% ROE. Recent Q1 2026 earnings matched expectations while the company pursues growth through outlet store strategies.
The outlook remains positive with analyst consensus favoring Buy ratings (53.57%) and improving cash flow trends. Key risks include competitive pressures in Chinese e-commerce and macroeconomic headwinds, but strong fundamentals and institutional support suggest potential for upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →
